en
Scientific article
English

HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation

Published inBlood, vol. 136, no. 3, p. 362-369
Publication date2020
Abstract

Hematopoietic cell transplantation (HCT) from HLA-mismatched unrelated donors can cure life-threatening blood disorders, but its success is limited by graft-versus-host disease (GVHD). HLA-B leaders encode methionine (M) or threonine (T) at position 2 and give rise to TT, MT, or MM genotypes. The dimorphic HLA-B leader informs GVHD risk in HLA-B-mismatched HCT. If the leader influences outcome in other HLA-mismatched transplant settings, the success of HCT could be improved for future patients. We determined leader genotypes for 10 415 patients receiving a transplant between 1988 and 2016 from unrelated donors with one HLA-A, HLA-B, HLA-C, HLA-DRB1, or HLA-DQB1 mismatch. Multivariate regression methods were used to evaluate risks associated with patient leader genotype according to the mismatched HLA locus and with HLA-A, HLA-B, HLA-C, HLA-DRB1, or HLA-DQB1 mismatching according to patient leader genotype. The impact of the patient leader genotype on acute GVHD and mortality varied across different mismatched HLA loci. Nonrelapse mortality was higher among HLA-DQB1-mismatched MM patients compared with HLA-DQB1-mismatched TT patients (hazard ratio, 1.35; P = .01). Grades III to IV GVHD risk was higher among HLA-DRB1-mismatched MM or MT patients compared with HLA-DRB1-mismatched TT patients (odds ratio, 2.52 and 1.51, respectively). Patients tolerated a single HLA-DQB1 mismatch better than mismatches at other loci. Outcome after HLA-mismatched transplantation depends on the HLA-B leader dimorphism and the mismatched HLA locus. The patient's leader variant provides new information on the limits of HLA mismatching. The success of HLA-mismatched unrelated transplantation might be enhanced through the judicious selection of mismatched donors for a patient's leader genotype.

Citation (ISO format)
PETERSDORF, Effie W et al. HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation. In: Blood, 2020, vol. 136, n° 3, p. 362–369. doi: 10.1182/blood.2020005743
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0006-4971
272views
0downloads

Technical informations

Creation02/04/2021 9:50:00 AM
First validation02/04/2021 9:50:00 AM
Update time03/16/2023 12:07:13 AM
Status update03/16/2023 12:07:12 AM
Last indexation01/17/2024 12:31:25 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack